1 Grant
2019
Development of a novel antiangiogenic drug for colon cancer by targeting neuropeptide Y receptors
Sarkar, Chandrani
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R21CA216763-03), $90,098USD, 2018-04-01 -- 2022-03-31